Research Funding

American Association for Cancer Research Invites LOIs for Cancer Research

Deadline: July 13, 2020
Link to RFP

The American Association for Cancer Research is inviting applications for its AACR-The Mark Foundation for Cancer Research “Science of the Patient” (SOP) Grants Program.

The program represents a joint effort to stimulate novel research aimed at understanding the influence of the biology of the host (i.e., patient) on the genesis, development, treatment, and survivorship of cancer. Successful projects should emphasize the interplay of host physiological systems with the tumor and/or tumor microenvironment. With a focus on harnessing powerful approaches to examining cancer not as an isolated phenomenon but as a systemic disease that affects and is affected by both the normal and pathological functions of the patient’s body, the grants are expected to yield important advancements in the understanding of cancer development, progression, and treatment.

Grants of up to $750,000 over three years will be awarded in support of highly innovative approaches to a major problem or challenge in cancer research. Individuals with innovative ideas that have the potential to affect future clinical practice are particularly encouraged to apply. 

To be eligible, applicants must have a doctoral degree (including PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. Investigators may be employed by an academic, medical, or research institution anywhere in the world. Postdoctoral or clinical research fellows or the equivalent who are working under the auspices of a scientific mentor are not eligible to apply. (Qualified fellows are invited to apply for an AACR Fellowship.)

Letters of Intent are due July 13. Upon review, selected applicants will be invited to submit a full application by October 6, 2020.

See the American Association for Cancer Research website for complete program guidelines and application instructions.

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.